AM Best Assigns Credit Ratings to HDI Global UK Limited
The ratings reflect HDI Global UK's inclusion as a member of the lead rating unit of HDI V.a.G., which has a balance sheet strength that AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management.
HDI Global UK is strategically important to HDI V.a.G. as its carrier for writing delegated authority business (retail and small and medium-sized enterprises, as well as liability, motor and high net worth business in the UK.
HDI Global UK was established in 2024, as a UK-incorporated subsidiary of HDI Global SE. The company is identified easily as part of HDI V.a.G., carrying the same brand. Given the strategic importance of the company to HDI V.a.G., AM Best expects that sufficient support will be provided promptly by the HDI V.a.G. group, should it be needed.
This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.
AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.
Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250724428362/en/
Contacts
Andrea Porta
Senior Financial Analyst
+31 20 808 1700
andrea.porta@ambest.com
Angela Yeo
Senior Director, Analytics
+31 20 808 1712
angela.yeo@ambest.com
Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com
Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Chelsea's Xavi Simons deal in danger! RB Leipzig refusing to take back Blues outcasts in deal as talks continue for Dutch forward
Chelsea's swap deal for Simons hits major roadblock RB Leipzig demand £60m — reject all swap offers Agent Ali Barat working to unlock transfer breakthrough Follow GOAL on WhatsApp! 🟢📱 WHAT HAPPENED? As per The Sun, Chelsea have offered multiple players in exchange for Simons, including Armando Broja and Carney Chukwuemeka. However, RB Leipzig are only interested in a cash deal worth £60m ($79m) for the Dutch international. Agent Ali Barat, who has good relations with Chelsea, is said to be working behind the scenes to try and rescue the transfer. THE BIGGER PICTURE Simons joined RB Leipzig permanently from Paris Saint-Germain in January after a loan stint with the Bundesliga side. His decision to leave comes after Leipzig failed to secure Champions League qualification. Chelsea, meanwhile, are making other moves in the market, sending Kendry Paez, Mike Penders, and Marc Guiu out on loan to open up the budget to sign Simons. DID YOU KNOW? RB Leipzig paid a club-record £43m for Simons, with add-ons potentially raising the deal to £70m. As such, Die Roten Bullen are not ready to sell the Dutchman for less than £60m. The Blues still view Simons as a priority target for the summer, despite the recent setback. WHAT NEXT FOR SIMONS? Negotiations are expected to continue as Chelsea weigh up whether to meet RB Leipzig's asking price for Simons. The Blues could return with a fresh offer later in the window if Barat finds a breakthrough. Meanwhile, other midfield options may be explored as a backup plan.
Yahoo
an hour ago
- Yahoo
Jim Cramer Says He's 'Worried About Brighthouse Financial'
Brighthouse Financial, Inc. (NASDAQ:BHF) is one of the stocks Jim Cramer shared insights on. A caller asked if they should buy, sell, or hold the stock, and Cramer stated: 'I'm worried about Brighthouse Financial… I prefer Chubb if I'm going to be in insurance business. I know Chubb has been a weak stock of late, but it's also 12 times earnings. I'm always willing to buy Chubb at 12 times earnings.' bluebay/ Brighthouse (NASDAQ:BHF) provides annuity and life insurance products designed to support wealth accumulation, income protection, and financial security. The company also manages legacy insurance obligations. Greenlight Capital stated the following regarding Brighthouse Financial, Inc. (NASDAQ:BHF) in its Q1 2025 investor letter: 'The biggest long winner was Brighthouse Financial, Inc. (NASDAQ:BHF), which rose 20.7% during the quarter. According to media reports, the company has hired Goldman Sachs and Wells Fargo to sell itself. There appears to be a lot of interest from large asset managers that would like the opportunity to manage BHF's approximately $120 billion general account. While there is a risk the current market turbulence could derail a deal, absent that we expect the company will be successful in selling itself at a healthy premium.' While we acknowledge the potential of BHF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
2 hours ago
- Yahoo
Proto Labs Inc (PRLB) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
Revenue: $135.1 million, a company record, up 6.5% year over year in constant currencies, and up 7% sequentially. CNC Machining Revenue: Grew 20% over the prior year, with a 30% increase in the US. Injection Molding Revenue: Declined 4% year over year. 3D Printing Revenue: Down 1% year over year. Sheet Metal Revenue: Grew 9% year over year. US Revenue: Grew 12% year over year. Europe Revenue: Declined 15% in constant currencies. Non-GAAP Gross Margin: 44.8%, flat sequentially, down 90 basis points year over year. Non-GAAP Operating Expenses: Increased $2.7 million, up 6% consistent with revenue. Adjusted EBITDA: $19.7 million, or 14.6% of revenue. Non-GAAP Earnings Per Share: $0.41, above guidance range, up $0.08 sequentially, and up $0.03 year over year. Cash from Operations: $10.6 million generated during the second quarter. Share Repurchases: $3.1 million returned to shareholders. Cash and Investments: $123.2 million on balance sheet with zero debt. Q3 2025 Revenue Guidance: Expected between $130 million and $138 million, implying 6% growth year over year in constant currencies. Q3 2025 Non-GAAP EPS Guidance: Expected between $0.35 and $0.43. Warning! GuruFocus has detected 7 Warning Signs with PRLB. Release Date: July 31, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Proto Labs Inc (NYSE:PRLB) delivered record revenue of $135.1 million in the second quarter, exceeding expectations. The company saw a 44% growth in customers utilizing their combined offer over the trailing 12 months. Revenue per customer increased by 11% year over year, indicating strong customer engagement. The metal 3D Printing service in Raleigh, North Carolina received ISO 13,485 certification, enhancing credibility in the medical device manufacturing sector. Proto Labs Inc (NYSE:PRLB) continues to generate healthy cash flows, allowing for ongoing investments in growth and innovation. Negative Points Injection Molding revenue declined by 4% year over year, with noted weakness in the medical sector. 3D Printing revenue was down 1% year over year, reflecting continued weakness in prototyping. European revenue declined by 15% in constant currencies, indicating challenges in the region. Tariffs and changing trade policies created short-term margin pressures, impacting profitability. Gross margin was down 90 basis points year over year, driven by higher growth in network revenue and lower US network margins due to tariffs. Q & A Highlights Q: Can you elaborate on the strength you're seeing in CNC, particularly in terms of growth across the factory and network? A: Daniel Schumacher, CFO: We are experiencing similar growth in both the factory and the network, with a 30% CNC growth in the US driving the overall 20% growth for the company. Suresh Krishna, CEO: We've grown revenues with larger accounts due to our go-to-market reorganization, and our production teams have shown agility in responding to customer needs. Q: Is the CNC work leaning more towards production or prototyping? A: Daniel Schumacher, CFO: It is a combination of both production and prototyping. We don't provide a specific split, but both contribute to our revenue growth. Q: Can you provide more details on the Injection Molding business and the factors affecting its performance? A: Daniel Schumacher, CFO: The network is a small portion of our Injection Molding business, with most of it through the factory. We saw some larger production orders last year, particularly in automotive, which impacted year-over-year comparisons. Currently, we are seeing weakness in the medical sector, but we continue to innovate and add capabilities to drive future production growth. Q: What excites you about joining Proto Labs, and what are your initial observations? A: Suresh Krishna, CEO: I'm excited about the opportunity to reaccelerate growth. My focus is on listening to employees, customers, and partners to remove friction and identify future opportunities. I believe there is significant potential to enhance customer and employee experiences. Q: Can you explain the impact of tariffs on gross margins and how it was addressed? A: Daniel Schumacher, CFO: Tariffs impacted our US network margins, particularly on aluminum and steel. We adjusted pricing and fulfillment strategies, and by June, margins returned to normal. The impact was due to a backlog priced at different assumptions, but adjustments have since stabilized margins. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
